Twitter Inc TWTR 0.26% can be an extremely useful and tradable tool for investors, but only if you follow the right people.
Here’s a look at 11 biotech and pharmaceutical company CEOs that have the potential for market-moving tweets.
1. Brent Saunders – @brentlsaunders
Saunders is the head of Allergen plc Ordinary Shares AGN 0.76%, a $100 billion drug company that makes eye care, skin care and aesthetic products such as Botox.
2. Richard Pops – @popsalks
The CEO of Alkermes Plc ALKS 0.85% is an active tweeter, and his company has a portfolio of about 20 drug candidates for treatment of central nervous system disorders.
3. Daphne Zohar – @daphnezohar
The CEO of Puretech Health frequently tweets about “medicine, startups, financing & other things that seem interesting.”
4. Jeff Stein – @jefflstein
Stein is the CEO of Cidara Therapeutics Inc CDTX 1.44% and actively tweets about biotech news. Cidara is developing anti-infectives with a focus on serious fungal infections.
5. Hans Bishop – @HansBishop1
Bishop is the CEO of Juno Therapeutics Inc JUNO 2.9%, one of many biotech companies working on novel treatments for cancer.
6. Tim Mayleben – @TimMayleben
Mayleben is the CEO of Esperion Therapeutics Inc ESPR 0.23%, a biotech company working on treatments for patients with elevated low-density lipoprotein cholesterol (LDL-C).
7. Katrine Bosley – @ksbosley
Bosley is the CEO of Editas Medicine Inc EDIT 3.76%, a genome editing company focused on correcting disease-causing genes.
8. Brian Culley – @CEO_Culley
Culley is the CEO of Mast Therapeutics Inc MSTX 6.36%, a biopharmaceutical company focused on treating life-threatening conditions such as sickle cell disease and heart failure.
9. Christian Homsy – @ChristianHomsy
The CEO of Celyad SA (ADR) CYAD 0.09% has just 31 tweets since 2012, but they are all biotech news items relevant for traders.
10. Paul Tunnah – @pharmaphorum
Tunnah’s company pharmaphorum isn’t actually performing biotech R&D. Instead, it’s…
Click here to continue reading
Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!
